Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H23NO4 |
| Molecular Weight | 281.3474 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H]2C[C@@H](CC(N)=O)CC(=O)O2
InChI
InChIKey=SAVFIMRLAWCZGX-UHFZAUJKSA-N
InChI=1S/C15H23NO4/c1-8-3-9(2)15(19)11(4-8)12-5-10(6-13(16)17)7-14(18)20-12/h8-12H,3-7H2,1-2H3,(H2,16,17)/t8-,9-,10-,11-,12+/m0/s1
| Molecular Formula | C15H23NO4 |
| Molecular Weight | 281.3474 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9711215
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9711215
A bone resorption inhibitor, A-75943, isolated from the fermentation broth of Streptomyces sp. SANK 61296, was found to be structurally related to cycloheximide, from which A-75943 was prepared chemically.
A-75943 inhibited in vitro bone resorption in a concentration-dependent manner, with maximal nontoxic inhibition greater than 90% at 5ug/ml and an
IC50 of 0.35uM.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0045453 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9711215 |
0.35 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9711215
Rat accelerated bone resorption model: Among three Ro-136298-treated groups, two groups received a concomitant daily subcutaneous administration of A-75943 (3 and 30mg/kg), and the remaining group received vehicle from the 4th to the 10th day following TPTX.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9711215
A-75943 inhibited in vitro bone resorption in a concentration-dependent manner, with maximal nontoxic inhibition greater than 90% at 5 ug/ml and an
IC50 of 0.35 uM. At higher concentrations, A-75943 exhibited cytotoxicity and significantly decreased the survival of osteoclasts on bone slices; but at lower
concentrations it did not affect the survival or morphology of osteoclasts.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:00:05 GMT 2025
by
admin
on
Mon Mar 31 23:00:05 GMT 2025
|
| Record UNII |
K78I00AA67
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
201215-10-3
Created by
admin on Mon Mar 31 23:00:05 GMT 2025 , Edited by admin on Mon Mar 31 23:00:05 GMT 2025
|
PRIMARY | |||
|
9925726
Created by
admin on Mon Mar 31 23:00:05 GMT 2025 , Edited by admin on Mon Mar 31 23:00:05 GMT 2025
|
PRIMARY | |||
|
K78I00AA67
Created by
admin on Mon Mar 31 23:00:05 GMT 2025 , Edited by admin on Mon Mar 31 23:00:05 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |